Exact Mass: 571.1277144000001

Exact Mass Matches: 571.1277144000001

Found 33 metabolites which its exact mass value is equals to given mass value 571.1277144000001, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Cyclochlorotine

(3S,7R,9S,13S,16R)-17,18-dichloro-13-ethyl-3,9-bis(hydroxymethyl)-7-phenyl-1,4,8,11,14-pentazabicyclo[14.3.0]nonadecane-2,5,10,12,15-pentone

C24H31Cl2N5O7 (571.1600436)


   

Islanditoxin

17,18-dichloro-7-ethyl-1,5,8,11-tetrahydroxy-10,13-bis(hydroxymethyl)-3-phenyl-3H,4H,7H,10H,13H,14H,16H,17H,18H,18aH-pyrrolo[2,1-c]1,4,7,10,13-pentaazacyclohexadecan-14-one

C24H31Cl2N5O7 (571.1600436)


Islanditoxin is a mycotoxin produced by the common food storage mould Penicillium islandicu

   

Cyclochlorotine

17,18-dichloro-3-ethyl-6,13-bis(hydroxymethyl)-9-phenyl-octadecahydropyrrolo[1,2-d]1,4,7,10,13-pentaazacyclohexadecane-1,4,7,11,14-pentone

C24H31Cl2N5O7 (571.1600436)


Cyclochlorotine is a mycotoxin produced by the common food storage mould Penicillium islandicu

   

4-O-alpha-L-Rhamnopyranosylglucosinalbin

{[(e)-(1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulphanyl}-2-{4-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]phenyl}ethylidene)amino]oxy}sulphonic acid

C20H29NO14S2 (571.1029414000001)


4-O-alpha-L-Rhamnopyranosylglucosinalbin is found in fats and oils. 4-O-alpha-L-Rhamnopyranosylglucosinalbin is a constituent of Moringa oleifera (horseradish tree) and Moringa peregrina Constituent of Moringa oleifera (horseradish tree) and Moringa peregrina. Glucosinalbin 4-rhamnoside is found in fats and oils, herbs and spices, and green vegetables.

   

Baloxavir marboxil

[(2-{12,13-difluoro-9-thiatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3,5,7,12,14-hexaen-2-yl}-9,12-dioxo-5-oxa-1,2,8-triazatricyclo[8.4.0.0^{3,8}]tetradeca-10,13-dien-11-yl)oxy]methyl methyl carbonate

C27H23F2N3O7S (571.1224712000001)


   

Telaglenastat

2-(pyridin-2-yl)-N-{5-[4-(6-{2-[3-(trifluoromethoxy)phenyl]acetamido}pyridazin-3-yl)butyl]-1,3,4-thiadiazol-2-yl}acetamide

C26H24F3N7O3S (571.161335)


C471 - Enzyme Inhibitor Telaglenastat (CB-839) is a first-in-class, selective, reversible and orally active glutaminase 1 (GLS1) inhibitor. Telaglenastat selectively inhibits GLS1 splice variants KGA (kidney-type glutaminase) and GAC (glutaminase C) compared to GLS2. The IC50s are 23 nM and 28 nM for endogenous glutaminase in mouse kidney and brain, respectively. Telaglenastat inuduces autophagy and has antitumor activity[1].

   

2-(alpha-L-Arabinopyranosyloxyl)-2-phenylethyl glucosinolate

2-(alpha-L-Arabinopyranosyloxyl)-2-phenylethyl glucosinolate

C20H29NO14S2 (571.1029414000001)


   

2-(alpha-L-Rhamnopyranosyloxy)benzyl glucosinolate

2-(alpha-L-Rhamnopyranosyloxy)benzyl glucosinolate

C20H29NO14S2 (571.1029414000001)


   

7-deoxo-7-hydroxyrebeccamycin

7-deoxo-7-hydroxyrebeccamycin

C27H23Cl2N3O7 (571.0912988)


   
   

Islanditoxin

17,18-dichloro-7-ethyl-10,13-bis(hydroxymethyl)-3-phenyl-octadecahydropyrrolo[2,1-c]1,4,7,10,13-pentaazacyclohexadecane-1,5,8,11,14-pentone

C24H31Cl2N5O7 (571.1600436)


   

4-O-a-L-Rhamnopyranosylglucosinalbin

{[(E)-(1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}-2-{4-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]phenyl}ethylidene)amino]oxy}sulfonic acid

C20H29NO14S2 (571.1029414000001)


   

Cobalt phthalocyanine

Cobalt phthalocyanine

C32H16CoN8 (571.0829836)


   

Benzamide, N-[1-[(2R)-3,5-di-O-benzoyl-2-deoxy-2-fluoro-2-methyl-α-D-erythro-pentofuranosyl]-1,2-dihydro-2-oxo-4-pyrimidinyl]

Benzamide, N-[1-[(2R)-3,5-di-O-benzoyl-2-deoxy-2-fluoro-2-methyl-α-D-erythro-pentofuranosyl]-1,2-dihydro-2-oxo-4-pyrimidinyl]

C31H26FN3O7 (571.1754698)


   

baloxavir marboxil

baloxavir marboxil

C27H23F2N3O7S (571.1224712000001)


J - Antiinfectives for systemic use > J05 - Antivirals for systemic use > J05A - Direct acting antivirals D000890 - Anti-Infective Agents > D000998 - Antiviral Agents C254 - Anti-Infective Agent > C281 - Antiviral Agent D004791 - Enzyme Inhibitors

   

(2R)-N-Benzoyl-2-deoxy-2-fluoro-2-methylcytidine 3,5-dibenzoate

(2R)-N-Benzoyl-2-deoxy-2-fluoro-2-methylcytidine 3,5-dibenzoate

C31H26FN3O7 (571.1754698)


   

(6-phthalimidohexyl)triphenylphosphonium bromide

(6-phthalimidohexyl)triphenylphosphonium bromide

C32H31BrNO2P (571.1275656)


   

Imidazol-3-ide;osmium(2+);2-pyridin-2-ylpyridine

Imidazol-3-ide;osmium(2+);2-pyridin-2-ylpyridine

C23H19N6Os+ (571.1277144000001)


   

Telaglenastat

Telaglenastat

C26H24F3N7O3S (571.161335)


C471 - Enzyme Inhibitor Telaglenastat (CB-839) is a first-in-class, selective, reversible and orally active glutaminase 1 (GLS1) inhibitor. Telaglenastat selectively inhibits GLS1 splice variants KGA (kidney-type glutaminase) and GAC (glutaminase C) compared to GLS2. The IC50s are 23 nM and 28 nM for endogenous glutaminase in mouse kidney and brain, respectively. Telaglenastat inuduces autophagy and has antitumor activity[1].

   
   

dTDP-2,3,6-trideoxy-3-C-methyl-4-O-methyl-3-nitroso-beta-L-arabino-hexopyranose

dTDP-2,3,6-trideoxy-3-C-methyl-4-O-methyl-3-nitroso-beta-L-arabino-hexopyranose

C18H27N3O14P2-2 (571.0968222)


   

N-[(2R,3R)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-2-pyrazinecarboxamide

N-[(2R,3R)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-2-pyrazinecarboxamide

C28H31Cl2N5O4 (571.1752986)


   

N-[(2R,3S)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-2-pyrazinecarboxamide

N-[(2R,3S)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-2-pyrazinecarboxamide

C28H31Cl2N5O4 (571.1752986)


   

N-[(2S,3R)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-2-pyrazinecarboxamide

N-[(2S,3R)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-2-pyrazinecarboxamide

C28H31Cl2N5O4 (571.1752986)


   

N-[(2R,3R)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-2-pyrazinecarboxamide

N-[(2R,3R)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-2-pyrazinecarboxamide

C28H31Cl2N5O4 (571.1752986)


   

N-[(2S,3S)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-2-pyrazinecarboxamide

N-[(2S,3S)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-2-pyrazinecarboxamide

C28H31Cl2N5O4 (571.1752986)


   

(3S,7R,9S,13S,16R)-17,18-dichloro-13-ethyl-3,9-bis(hydroxymethyl)-7-phenyl-1,4,8,11,14-pentazabicyclo[14.3.0]nonadecane-2,5,10,12,15-pentone

(3S,7R,9S,13S,16R)-17,18-dichloro-13-ethyl-3,9-bis(hydroxymethyl)-7-phenyl-1,4,8,11,14-pentazabicyclo[14.3.0]nonadecane-2,5,10,12,15-pentone

C24H31Cl2N5O7 (571.1600436)


   

17,18-Dichloro-9-ethyl-3,6-bis(hydroxymethyl)-13-phenyl-1,4,7,10,14-pentazabicyclo[14.3.0]nonadecane-2,5,8,11,15-pentone

17,18-Dichloro-9-ethyl-3,6-bis(hydroxymethyl)-13-phenyl-1,4,7,10,14-pentazabicyclo[14.3.0]nonadecane-2,5,8,11,15-pentone

C24H31Cl2N5O7 (571.1600436)


   

CMP-3-deoxy-D-glycero-beta-D-galacto-nonulosonate(2-)

CMP-3-deoxy-D-glycero-beta-D-galacto-nonulosonate(2-)

C18H26N3O16P (571.1050646)


A nucleotide-sugar oxoanion obtained by deprotonation of the carboxylic acid and phosphate functions of CMP-3-deoxy-D-glycero-beta-D-galacto-nonulosonic acid; major species at pH 7.3.

   

17,18-dichloro-3-ethyl-1,4,7,11-tetrahydroxy-6,13-bis(hydroxymethyl)-9-phenyl-3h,6h,9h,10h,13h,16h,17h,18h,18ah-pyrrolo[1,2-d]1,4,7,10,13-pentaazacyclohexadecan-14-one

17,18-dichloro-3-ethyl-1,4,7,11-tetrahydroxy-6,13-bis(hydroxymethyl)-9-phenyl-3h,6h,9h,10h,13h,16h,17h,18h,18ah-pyrrolo[1,2-d]1,4,7,10,13-pentaazacyclohexadecan-14-one

C24H31Cl2N5O7 (571.1600436)


   

[(e)-[(3s)-3-phenyl-1-{[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}-3-{[(2r,3r,4r,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}propylidene]amino]oxysulfonic acid

[(e)-[(3s)-3-phenyl-1-{[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}-3-{[(2r,3r,4r,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}propylidene]amino]oxysulfonic acid

C20H29NO14S2 (571.1029414000001)


   

3,25-dihydroxy-7-(hydroxymethyl)-24-methoxy-7,10-dimethyl-9,20-dioxa-6-azaheptacyclo[15.12.0.0²,¹⁴.0⁴,¹².0⁶,¹⁰.0¹⁹,²⁸.0²¹,²⁶]nonacosa-1(17),2,4(12),13,15,19(28),21,23,25-nonaene-5,8,18,27,29-pentone

3,25-dihydroxy-7-(hydroxymethyl)-24-methoxy-7,10-dimethyl-9,20-dioxa-6-azaheptacyclo[15.12.0.0²,¹⁴.0⁴,¹².0⁶,¹⁰.0¹⁹,²⁸.0²¹,²⁶]nonacosa-1(17),2,4(12),13,15,19(28),21,23,25-nonaene-5,8,18,27,29-pentone

C30H21NO11 (571.1114556)


   

[(z)-(1-{[(2r,3r,4s,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}-2-(4-{[(2s,3r,4s,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}phenyl)ethylidene)amino]oxysulfonic acid

[(z)-(1-{[(2r,3r,4s,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}-2-(4-{[(2s,3r,4s,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}phenyl)ethylidene)amino]oxysulfonic acid

C20H29NO14S2 (571.1029414000001)